
Fred D. Zemel
Partner
201-896-7065 fzemel@sh-law.comFirm Insights
Author: Fred D. Zemel
Date: December 29, 2017
Partner
201-896-7065 fzemel@sh-law.comIn his first public remarks, Makan Delrahim, the new head of the Department of Justice’s (DOJ) Antitrust Division, outlined several changes that will impact how the agency approaches antitrust cases. Most notably, Delrahim indicated that the DOJ will limit the use of “behavioral remedies” to address legal concerns with proposed mergers. “[I]f a merger is illegal, we should only accept a clean and complete solution, but if the merger is legal we should not impose behavioral conditions just because we can do so to expand our power and because the merging parties are willing to agree to get their merger through,” he stated.
In his remarks at the American Bar Association’s Antitrust Fall Forum, Delrahim noted that he is frequently asked how President Trump’s directive to reduce federal regulations will impact the enforcement of the antitrust laws. He started by stating that antitrust is law enforcement, not regulation. He added:
At its best, it supports reducing regulation, by encouraging competitive markets that, as a result, require less government intervention. That is to say, proper and timely antitrust enforcement helps competition police markets instead of bureaucrats in Washington, D.C. doing it. Vigorous antitrust enforcement plays an important role in building a less regulated economy in which innovation and business can thrive, and ultimately the American consumer can benefit.
Delrahim went on to address how this approach will impact the agency’s use of behavioral commitments, which he characterized as “fundamentally regulatory, imposing ongoing government oversight on what should preferably be a free market.” In his remarks, Delrahim outlined several theoretical and practical criticisms regarding the use of behavioral remedies to address antitrust concerns.
Theoretically, Delrahim argued that a behavioral remedy interferes with the free market process by “supplanting competition with regulation” and replacing “disaggregated decision making with central planning.” He also noted several practical problems, namely that consent decrees are difficult to both draft and enforce. “Behavioral remedies often require companies to make daily decisions contrary to their profit-maximizing incentives, and they demand ongoing monitoring and enforcement to do that effectively,” he stated. In support, Delrahim noted several instances where the DOJ found consent decrees were being violated but found it too onerous to collect information or satisfy the exacting standards of proving contempt and seeking relief for violations.
Delrahim emphasized that he was not saying that the DOJ would never accept behavioral remedies. “In certain instances where an unlawful vertical transaction generates significant efficiencies that cannot be achieved without the merger or through a structural remedy, then there’s a place for considering a behavioral remedy if it will completely cure the anticompetitive harms,” he stated. As far as what types of consent decrees might meet the DOJ’s new “high standard,” Delrahim stated the agency should only settle federal antitrust violations when it has a “high degree of confidence that the remedy does not usurp regulatory functions for law enforcement.”
The policy shift may have played a role in the DOJ’s decision to challenge the proposed merger between AT&T and Time Warner. “This merger would greatly harm American consumers,” Delrahim said in a statement. “It would mean higher monthly television bills and fewer of the new, emerging innovative options that consumers are beginning to enjoy. AT&T/DirecTV’s combination with Time Warner is unlawful, and absent an adequate remedy that would fully prevent the harms this merger would cause, the only appropriate action for the Department of Justice is to seek an injunction from a federal judge blocking the entire transaction.”
In the past, the DOJ has rarely challenged vertical mergers, largely because they do not involve direct competitors. In 2011, the proposed merger of Comcast and NBCUniversal resulted in a consent decree, the type of remedy Delrahim announced would no longer be a preferred option for the DOJ.
Do you have any questions? Would you like to discuss the decisions further? If so, please contact me, Fred Zemel, at 201-806-3364.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Your home is likely your greatest asset, which is why it is so important to adequately protect it. Homeowners insurance protects you from the financial costs of unforeseen losses, such as theft, fire, and natural disasters, by helping you rebuild and replace possessions that were lost While the definition of “adequate” coverage depends upon a […]
Author: Jesse M. Dimitro
Making a non-contingent offer can dramatically increase your chances of securing a real estate transaction, particularly in competitive markets like New York City. However, buyers should understand that waiving contingencies, including those related to financing, or appraisals, also comes with significant risks. Determining your best strategy requires careful analysis of the property, the market, and […]
Author: Jesse M. Dimitro
Business Transactional Attorney Zemel to Spearhead Strategic Initiatives for Continued Growth and Innovation Little Falls, NJ – February 21, 2025 – Scarinci & Hollenbeck, LLC is pleased to announce that Partner Fred D. Zemel has been named Chair of the firm’s Strategic Planning Committee. In this role, Mr. Zemel will lead the committee in identifying, […]
Author: Scarinci Hollenbeck, LLC
Big changes sometimes occur during the life cycle of a contract. Cancelling a contract outright can be bad for your reputation and your bottom line. Businesses need to know how to best address a change in circumstances, while also protecting their legal rights. One option is to transfer the “benefits and the burdens” of a […]
Author: Dan Brecher
What is a trade secret and why you you protect them? Technology has made trade secret theft even easier and more prevalent. In fact, businesses lose billions of dollars every year due to trade secret theft committed by employees, competitors, and even foreign governments. But what is a trade secret? And how do you protect […]
Author: Ronald S. Bienstock
If you are considering the purchase of a property, you may wonder — what is title insurance, do I need it, and why do I need it? Even seasoned property owners may question if the added expense and extra paperwork is really necessary, especially considering that people and entities insured by title insurance make fewer […]
Author: Patrick T. Conlon
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
In his first public remarks, Makan Delrahim, the new head of the Department of Justice’s (DOJ) Antitrust Division, outlined several changes that will impact how the agency approaches antitrust cases. Most notably, Delrahim indicated that the DOJ will limit the use of “behavioral remedies” to address legal concerns with proposed mergers. “[I]f a merger is illegal, we should only accept a clean and complete solution, but if the merger is legal we should not impose behavioral conditions just because we can do so to expand our power and because the merging parties are willing to agree to get their merger through,” he stated.
In his remarks at the American Bar Association’s Antitrust Fall Forum, Delrahim noted that he is frequently asked how President Trump’s directive to reduce federal regulations will impact the enforcement of the antitrust laws. He started by stating that antitrust is law enforcement, not regulation. He added:
At its best, it supports reducing regulation, by encouraging competitive markets that, as a result, require less government intervention. That is to say, proper and timely antitrust enforcement helps competition police markets instead of bureaucrats in Washington, D.C. doing it. Vigorous antitrust enforcement plays an important role in building a less regulated economy in which innovation and business can thrive, and ultimately the American consumer can benefit.
Delrahim went on to address how this approach will impact the agency’s use of behavioral commitments, which he characterized as “fundamentally regulatory, imposing ongoing government oversight on what should preferably be a free market.” In his remarks, Delrahim outlined several theoretical and practical criticisms regarding the use of behavioral remedies to address antitrust concerns.
Theoretically, Delrahim argued that a behavioral remedy interferes with the free market process by “supplanting competition with regulation” and replacing “disaggregated decision making with central planning.” He also noted several practical problems, namely that consent decrees are difficult to both draft and enforce. “Behavioral remedies often require companies to make daily decisions contrary to their profit-maximizing incentives, and they demand ongoing monitoring and enforcement to do that effectively,” he stated. In support, Delrahim noted several instances where the DOJ found consent decrees were being violated but found it too onerous to collect information or satisfy the exacting standards of proving contempt and seeking relief for violations.
Delrahim emphasized that he was not saying that the DOJ would never accept behavioral remedies. “In certain instances where an unlawful vertical transaction generates significant efficiencies that cannot be achieved without the merger or through a structural remedy, then there’s a place for considering a behavioral remedy if it will completely cure the anticompetitive harms,” he stated. As far as what types of consent decrees might meet the DOJ’s new “high standard,” Delrahim stated the agency should only settle federal antitrust violations when it has a “high degree of confidence that the remedy does not usurp regulatory functions for law enforcement.”
The policy shift may have played a role in the DOJ’s decision to challenge the proposed merger between AT&T and Time Warner. “This merger would greatly harm American consumers,” Delrahim said in a statement. “It would mean higher monthly television bills and fewer of the new, emerging innovative options that consumers are beginning to enjoy. AT&T/DirecTV’s combination with Time Warner is unlawful, and absent an adequate remedy that would fully prevent the harms this merger would cause, the only appropriate action for the Department of Justice is to seek an injunction from a federal judge blocking the entire transaction.”
In the past, the DOJ has rarely challenged vertical mergers, largely because they do not involve direct competitors. In 2011, the proposed merger of Comcast and NBCUniversal resulted in a consent decree, the type of remedy Delrahim announced would no longer be a preferred option for the DOJ.
Do you have any questions? Would you like to discuss the decisions further? If so, please contact me, Fred Zemel, at 201-806-3364.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!